Syner-G Helps Biotech Firm Successfully Advance Life-Saving Drug Through Manufacturing Startup and Clinical Trials
June 3, 2024About The client is a clinical-stage biotechnology company focused on the phase III development of an anti-interleukin-6 monoclonal antibody therapeutic…Advancing Biotech Drug Development: Syner-G BioPharma’s Collaborative Approach to Chemistry, Manufacturing, and Controls
June 3, 2024About The client is a U.S.-based clinical-stage biotechnology company using artificial intelligence (AI) and human data to transform drug discovery…
Synthesizing Success: Syner-G’s Strategic Solutions for Elevating a Biotech Innovator
June 3, 2024About The client is an emerging biotechnology company focused on developing and commercializing patient-friendly compounds to treat psychiatric and neurological…Regulatory Expectations for Sterile Filtration Process Control
June 3, 2024Sterile filtration is a critical process step in the production of injectable drug products and is used to remove microorganisms…
